| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |